Nia Therapeutics key facts
as of Oct 2026- Developer of a neurostimulation device designed to stimulate memory for patients with traumatic brain injury.
- Nia Therapeutics is valued at approximately $69.0M as of Oct 2026, set at its seed round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $22.0M across 1 recorded rounds; the latest was Early Stage VC ($23.6M) in Dec 2021.
- Notable investors include Creative Destruction Lab, University of Toronto, University of Toronto Entrepreneurship, Johnson & Johnson Innovation - JLABS, Ben Franklin Technology Partners of Southeastern Pennsylvania — 10 tracked in total.
- Nia Therapeutics has filed 2 Form Ds with the SEC since 2025, most recently Mar 2026 ($18.8M sold to 33 investors).
- Status: Privately Held (backing).
Valued at $69.0M at its seed round, Jun 2025. Nothing has traded since.
- ·Watch Nia Therapeutics: the Monday email on marks, rounds and moves
Nia Therapeutics funding rounds
1 roundsWho backs Nia Therapeutics
10Nia Therapeutics valuation
Nia Therapeutics was valued at $69 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Nia Therapeutics raised?
Nia Therapeutics has raised $22 million across 1 recorded round since 2021. The largest was a $23.6 million early-stage round in Dec 2021.
Nia Therapeutics has filed 2 Form Ds with the SEC since 2025, most recently in Mar 2026 ($18.8 million sold to 33 investors).
Nia Therapeutics investors
10 investors are on record for Nia Therapeutics, including Creative Destruction Lab, University of Toronto, University of Toronto Entrepreneurship and Johnson & Johnson Innovation - JLABS. The early-stage round in Dec 2021 drew 37 investors.
About Nia Therapeutics
Developer of a neurostimulation device designed to stimulate memory for patients with traumatic brain injury. The company's device interprets the complex brain activity related to memory function and provides personalized therapy with the help of deep-brain stimulation devices, enabling patients with traumatic brain injury to improve memory by restoring the brain activity associated with good memory.
- Sector
- Healthcare
- HQ
- Allston, MA, United States
- Founded
- 2016
- Employees
- 17
- Website
- niatx.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.